Ex Vivo Perfusion-Simulation Measurements of Microbubbles as a Scattering Contrast Agent for Grating-Based X-Ray Dark-Field Imaging

The investigation of dedicated contrast agents for x-ray dark-field imaging, which exploits small-angle scattering at microstructures for contrast generation, is of strong interest in analogy to the common clinical use of high-atomic number contrast media in conventional attenuation-based imaging, since dark-field imaging has proven to provide complementary information. Therefore, agents consisting of gas bubbles, as used in ultrasound imaging for example, are of particular interest. In this work, we investigate an experimental contrast agent based on microbubbles consisting of a polyvinyl-alcohol shell with an iron oxide coating, which was originally developed for multimodal imaging and drug delivery. Its performance as a possible contrast medium for small-animal angiography was examined using a mouse carcass to realistically consider attenuating and scattering background signal. Subtraction images of dark field, phase contrast and attenuation were acquired for a concentration series of 100%, 10% and 1.3% to mimic different stages of dilution in the contrast agent in the blood vessel system. The images were compared to the gold-standard iodine-based contrast agent Solutrast, showing a good contrast improvement by microbubbles in dark-field imaging. This study proves the feasibility of microbubble-based dark-field contrast-enhancement in presence of scattering and attenuating mouse body structures like bone and fur. Therefore, it suggests a strong potential of the use of polymer-based microbubbles for small-animal dark-field angiography.

[1]  Gaio Paradossi,et al.  Stable polymeric microballoons as multifunctional device for biomedical uses: synthesis and characterization. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[2]  Franz Pfeiffer,et al.  Experimental results from a preclinical X-ray phase-contrast CT scanner , 2012, Proceedings of the National Academy of Sciences.

[3]  S Auweter,et al.  Quantitative breast tissue characterization using grating-based x-ray phase-contrast imaging , 2014, Physics in medicine and biology.

[4]  HighWire Press.  Philosophical Transactions of the Royal Society of London , 1781, The London Medical Journal.

[5]  Max A. Viergever,et al.  A survey of medical image registration , 1998, Medical Image Anal..

[6]  F. Pfeiffer,et al.  Imaging Liver Lesions Using Grating-Based Phase-Contrast Computed Tomography with Bi-Lateral Filter Post-Processing , 2014, PloS one.

[7]  A. Ignee,et al.  Ultrasound contrast agents , 2016, Endoscopic ultrasound.

[8]  Franz Pfeiffer,et al.  Emphysema diagnosis using X-ray dark-field imaging at a laser-driven compact synchrotron light source , 2012, Proceedings of the National Academy of Sciences.

[9]  Nataly Wieberneit,et al.  A Study on Mastectomy Samples to Evaluate Breast Imaging Quality and Potential Clinical Relevance of Differential Phase Contrast Mammography , 2014, Investigative radiology.

[10]  O. Bunk,et al.  Phase retrieval and differential phase-contrast imaging with low-brilliance X-ray sources , 2006 .

[11]  Franz Pfeiffer,et al.  Quantitative x-ray dark-field computed tomography , 2010, Physics in medicine and biology.

[12]  F. Pfeiffer,et al.  Microbubbles as a scattering contrast agent for grating-based x-ray dark-field imaging , 2013, Physics in medicine and biology.

[13]  Franz Pfeiffer,et al.  Beam hardening effects in grating-based x-ray phase-contrast imaging. , 2011, Medical physics.

[14]  Peter Modregger,et al.  High resolution, large field of view x-ray differential phase contrast imaging on a compact setup , 2011 .

[15]  F. Pfeiffer,et al.  Translation of Atherosclerotic Plaque Phase-Contrast CT Imaging from Synchrotron Radiation to a Conventional Lab-Based X-Ray Source , 2013, PloS one.

[16]  Michel Claudon,et al.  Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts , 2001, European Radiology.

[17]  Atsushi Momose,et al.  Cadaveric and in vivo human joint imaging based on differential phase contrast by X-ray Talbot-Lau interferometry. , 2013, Zeitschrift fur medizinische Physik.

[18]  Satya V. V. N. Kothapalli,et al.  Magnetite nanoparticles can be coupled to microbubbles to support multimodal imaging. , 2012, Biomacromolecules.

[19]  Franz Pfeiffer,et al.  Pulmonary emphysema diagnosis with a preclinical small-animal X-ray dark-field scatter-contrast scanner. , 2013, Radiology.

[20]  Franz Pfeiffer,et al.  Quantitative X-ray phase-contrast computed tomography at 82 keV. , 2013, Optics express.

[21]  Gerhard Martens,et al.  Clinical boundary conditions for grating-based differential phase-contrast mammography , 2014, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[22]  Franz Pfeiffer,et al.  Quantitative wave-optical numerical analysis of the dark-field signal in grating-based X-ray interferometry , 2012 .

[23]  F. Pfeiffer,et al.  In-vivo dark-field and phase-contrast x-ray imaging , 2013, Scientific Reports.

[24]  Mark Borden,et al.  Microbubble Compositions, Properties and Biomedical Applications. , 2009, Bubble science engineering and technology.

[25]  Franz Pfeiffer,et al.  X-ray phase imaging with a grating interferometer. , 2005, Optics express.

[26]  T. P. Millard,et al.  Quantification of microbubble concentration through x-ray phase contrast imaging , 2013 .

[27]  D. Hill,et al.  Non-rigid image registration: theory and practice. , 2004, The British journal of radiology.

[28]  P. Aspelin,et al.  Multimodality imaging using SPECT/CT and MRI and ligand functionalized 99mTc-labeled magnetic microbubbles , 2013, EJNMMI Research.

[29]  Sheila Podell,et al.  Physical and biochemical stability of Optison®, an injectable ultrasound contrast agent , 1999, Biotechnology and applied biochemistry.

[30]  R. Menk,et al.  Microbubbles as x-ray scattering contrast agents using analyzer-based imaging , 2010, Physics in medicine and biology.

[31]  Ashley F. Stein,et al.  Interpretation of dark-field contrast and particle-size selectivity in grating interferometers. , 2011, Applied optics.

[32]  A. Momose,et al.  On the origin of visibility contrast in x-ray Talbot interferometry. , 2010, Optics express.

[33]  Han Wen,et al.  A grating-based single-shot x-ray phase contrast and diffraction method for in vivo imaging. , 2010, Medical physics.

[34]  O. Bunk,et al.  Hard-X-ray dark-field imaging using a grating interferometer. , 2008, Nature materials.

[35]  Timm Weitkamp,et al.  X-ray vector radiography for bone micro-architecture diagnostics , 2012, Physics in medicine and biology.

[36]  M. Kaps,et al.  Ultrasound Contrast Agents and Imaging of Cerebrovascular Disease , 2005 .

[37]  S. Jalkanen,et al.  Nuclear imaging of inflammation: homing-associated molecules as targets , 2013, EJNMMI Research.

[38]  Marcus Radicke,et al.  On a dark-field signal generated by micrometer-sized calcifications in phase-contrast mammography , 2013, Physics in medicine and biology.

[39]  V.R.S Mani,et al.  Survey of Medical Image Registration , 2013 .

[40]  M. Takeda,et al.  Fourier-transform method of fringe-pattern analysis for computer-based topography and interferometry , 1982 .

[41]  M. Mahmoudi,et al.  Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. , 2011, Advanced drug delivery reviews.